Quality of Life in Phase II Trials: a Study of Methodology and Predictive Value in Patients With Advanced Breast Cancer Treated With Paclitaxel Plus Granulocyte Colony-Stimulating Factor-Reference-Cited by-同舟云学术

Quality of Life in Phase II Trials: a Study of Methodology and Predictive Value in Patients With Advanced Breast Cancer Treated With Paclitaxel Plus Granulocyte Colony-Stimulating Factor

Published:1995-09-06 Issue:17 Volume:87 Page:1316-1322
ISSN:0027-8874
Container-title:JNCI Journal of the National Cancer Institute
language:en
Short-container-title:JNCI Journal of the National Cancer Institute

Author:

Seidman A. D.,Portenoy R.,Yao T. -J.,Lepore J.,Mont E. K.,Kortmansky J.,Onetto N.,Ren L.,Grechko J.,Beltangady M.,Usakewicz J.,Southrada M.,Houston C.,McCabe M.,Salvaggio R.,Thaler H.,Norton L.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/87/17/1316/7809696/87-17-1316.pdf

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patient-Reported Outcome Measures Help Patients With Cancer;JAMA Network Open;2024-08-13

2. The effect of cognitive behavioral therapy on the quality of life of breast cancer patients: a systematic review and meta-analysis of randomized controlled trials;Quality of Life Research;2020-10-17

3. Low doses of Paclitaxel repress breast cancer invasion through DJ-1/KLF17 signalling pathway;Clinical and Experimental Pharmacology and Physiology;2018-05-23

4. Pretreatment quality of life, performance status and their relation to treatment discontinuation and treatment changes in high-risk breast cancer patients receiving chemotherapy: results from the prospective randomized ADEBAR trial;Breast Cancer;2016-06-04

5. The Complementary Nature of Patient-Reported Outcomes and Adverse Event Reporting in Cooperative Group Oncology Clinical Trials: A Pooled Analysis (NCCTG N0591);Journal of Pain and Symptom Management;2015-10